1）Kudo M, Hatanaka K, Maekawa K：Defect reperfusion imaging, a newly developed novel technology using sonazoid in the treatment of hepatocellular carcinoma. J Med Ultrasound 16：169-175, 2008
2）Sugimoto K, Shiraishi J, Moriyasu F, et al：Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid：observer performance study with JAFROC analysis. Acad Radiol 16：798-809, 2009
3）Gabata T, Matsui O, Terayama N, et al：Imaging diagnosis of hepatic metastases of pancreatic carcinomas：significance of transient wedge-shaped contrast enhancement mimicking arterioportal shunt. Abdom Imaging 33：437-443, 2008
4）Goshima S, Kanematsu M, Watanabe H, et al：Hepatic hemangioma and metastasis：differentiation with gadoxetate disodium-enhanced 3-t mri. AJR Am J Roentgenol 195：941-946, 2010
5）Saito K, Kotake F, Ito N, et al：Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma：quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4：1-9, 2005
6）Saito K, Araki Y, Park J, et al：Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 32：229-234, 2010
7）Takahara T, Imai Y, Yamashita T, et al：Diffusion weighted whole body imaging with background body signal suppression（DWIBS）：technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22：275-282, 2004
8）Kasuya K, Sugimoto K, Kyo B, et al：Ultrasonography-guided hepatic tumor resection using a real-time virtual sonography with indocyanine green navigation（with videos）. J Hepatobiliary Pancreat Sci. Epub 2010, Dec3.
9）Moriyasu F, Itoh K：Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions：phase 3 multicenter clinical trial. AJR Am J Roentgenol 193：86-95, 2009
10）Muhi A, Ichikawa T, Motosugi U, et al：Diagnosis of colorectal hepatic metastases：contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. J Magn Reson Imaging 32：1132-1140, 2010
11）Numata K, Luo W, Morimoto M, et al：Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 28：68-82, 2010
12）Nakano H, Ishida Y, Hatakeyama T, et al：Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 14：3207-3211, 2008
13）Nasu K, Kuroki Y, Nawano S, et al：Hepatic metastases：Diffusion-weighted sensitivity-encoding versus spio-enhanced mr imaging. Radiology 239：122-130, 2006
14）Shimada K, Isoda H, Hirokawa Y, et al：Comparison of gadolinium-eob-dtpa-enhanced and diffusion-weighted liver mri for detection of small hepatic metastases. Eur Radiol 20：2690-2698, 2010
15）Lowenthal D, Zeile M, Lim WY, et al：Detection and characterisation of focal liver lesions in colorectal carcinoma patients：comparison of diffusion-weighted and gd-eob-dtpa enhanced mr imaging. Eur Radiol 21：832-840, 2011
16）Adam R, Delvart V, Pascal G, et al：Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy：a model to predict long-term survival. Ann Surg 240：644-57, 2004
17）Alberts RS, Horvath WL, Sternfeld WC, et al：Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer：a north central cancer treatment group phase Ⅱ study. J Clin Oncol 23：9243-9249, 2005
18）Benoist S, Brouquet A, Penna C, et al：Complete response of colorectal liver metastases after chemotherapy：does it mean cure? J Clin Oncol 24：3939-3945, 2006
ログイン
ランキング
お知らせ
ログイン
